Revenue: The sum of all revenue fields included for a company's operating activities.
Ayala Pharmaceuticals, Inc. (ADXS) had Revenue of $0.00M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.00M |
$-24.67M |
|
$0.00M |
|
-- |
|
$8.78M |
|
$-8.78M |
|
$-15.79M |
|
$-24.57M |
|
$-24.57M |
|
$-24.67M |
|
$-24.67M |
|
$-24.67M |
|
$-24.67M |
|
$-8.78M |
|
$-8.55M |
|
6.02M |
|
6.02M |
|
$-2.97 |
|
$-2.97 |
|
| Balance Sheet Financials | |
$7.53M |
|
$0.54M |
|
$9.05M |
|
$16.58M |
|
$25.02M |
|
$8.14M |
|
$15.98M |
|
$41.00M |
|
$-24.42M |
|
$-32.81M |
|
$-24.42M |
|
11.86M |
|
| Cash Flow Statement Financials | |
$-29.48M |
|
$5.95M |
|
$26.00M |
|
$2.72M |
|
$5.21M |
|
$2.49M |
|
$1.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-0.50 |
|
-0.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.48M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
101.05% |
|
75.19% |
|
-148.82% |
|
151.59% |
|
$-2.06 |
|
$-4.23 |
|
$-4.90 |
|